City National Bank’s Biogen BIIB Stock Holding History

City National Bank’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$17.8M	Sell	60,831 -159,958	-72%	-$52.8M	0.15%	142
2015 Q2	$89.2M	Sell	220,789 -49,967	-18%	-$20.1M	0.74%	37
2015 Q1	$114M	Buy	270,756 +10,900	+4%	+$4.3M	0.96%	16
2014 Q4	$88.2M	Buy	259,856 +11,915	+5%	+$3.85M	0.77%	30
2014 Q3	$82M	Buy	247,941 +9,382	+4%	+$3.09M	0.75%	30
2014 Q2	$75.2M	Buy	238,559 +96,429	+68%	+$29M	0.69%	36
2014 Q1	$43.5M	Buy	142,130 +31,777	+29%	+$10.1M	0.61%	52
2013 Q4	$30.9M	Buy	110,353 +109,349	+10,891%	+$28.3M	0.46%	75
2013 Q3	$242K	Buy	+1,004	New	+$225K	﹤0.01%	655

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

City National Bank's BIIB Position: Q3 2015 in Review

City National Bank reduced its Biogen (BIIB) stake by 72% in Q3 2015, selling an estimated $52.8M and leaving 60,831 shares worth $17.8M. The position accounts for 0.15% of the portfolio, ranked #142.

City National Bank first reported a position in BIIB in Q3 2013 and has held it in 9 quarters since. The position peaked at $114M in Q1 2015. 923 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

City National Bank held 60,831 shares of Biogen worth $17.8M as of Q3 2015.
City National Bank sold 159,958 Biogen shares in Q3 2015, an estimated $52.8M.
Biogen made up 0.15% of City National Bank's portfolio in Q3 2015, its #142 holding.
City National Bank first reported a position in Biogen in Q3 2013 and has held it in 9 quarters since.
City National Bank's Biogen position peaked at $114M in Q1 2015.
923 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.